BlackRock Reduces Stake in Integer Holdings Co.
December 17, 2023
🌥️Trending News
Integer Holdings ($NYSE:ITGR) Co. (INTG) has recently seen a reduction in its stock holdings from BlackRock Inc. (BLK). INTG is a leading medical device outsource manufacturing company. It provides comprehensive design, engineering, manufacturing, and supply chain services to medical device companies, helping them to bring new solutions to market faster and more efficiently. The company operates through two business segments: Contract Manufacturing Services and O2 Control Solutions. BlackRock Inc. is one of the world’s leading asset management companies, providing services to clients across the globe.
Their decision to reduce their stake in INTG has caused a stir among those invested in the company. It has been speculated that the move was taken as a measure of caution in the face of uncertainty surrounding the medical device industry. Despite this, INTG remains an attractive investment opportunity for those looking to diversify their portfolio and capitalize on the long-term growth potential of the medical device sector.
Share Price
This news saw the stock of Integer Holdings open at $88.9 and close at $89.5, up by 0.7% from previous closing price of 88.9. The decrease in BlackRock’s stake in Integer Holdings could be seen as a vote of confidence in the company’s future prospects, although the full extent of the impact of this news is yet to be seen. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Integer Holdings. More…
| Total Revenues | Net Income | Net Margin |
| 1.56k | 82.41 | 5.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Integer Holdings. More…
| Operations | Investing | Financing |
| 176.23 | -114.11 | -49.47 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Integer Holdings. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.84k | 1.38k | 43.91 |
Key Ratios Snapshot
Some of the financial key ratios for Integer Holdings are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 11.2% | 11.9% | 9.9% |
| FCF Margin | ROE | ROA |
| 4.0% | 6.6% | 3.4% |
Analysis
At GoodWhale, we conducted an analysis of INTEGER HOLDINGS‘ fundamentals and generated a Star Chart to provide a comprehensive overview of the company’s performance. The Star Chart showed that INTEGER HOLDINGS is strong in growth and medium in profitability, asset and dividend. Furthermore, our health score analysis concluded that INTEGER HOLDINGS has a score of 8/10, indicating that it possesses strong cashflows and debt and is capable to safely ride out any crisis without the risk of bankruptcy. Moreover, our classification of INTEGER HOLDINGS as a ‘cheetah’ company reflects its high revenue or earnings growth but is considered less stable due to lower profitability. Therefore, we believe that investors looking for high growth companies with lower stability may be interested in INTEGER HOLDINGS. More…
Peers
The company designs, develops, manufactures, and markets medical devices and services worldwide. Integer’s competitors in the orthopedics industry include Polynovo Ltd, Globus Medical Inc, and Shenzhen Mindray Bio-Medical Electronics Co Ltd.
– Polynovo Ltd ($ASX:PNV)
Polynovo Ltd is a medical device company that designs, manufactures, and markets biodegradable scaffolds for use in tissue regeneration. The company has a market cap of 1.32B as of 2022 and a Return on Equity of -3.08%. Polynovo’s products are used in a variety of applications, including orthopedics, plastic surgery, and wound care. The company’s products are sold in over 30 countries worldwide.
– Globus Medical Inc ($NYSE:GMED)
Globus Medical Inc is a leading musculoskeletal solutions company. They design, develop, manufacture and market a comprehensive line of products for the orthopedic market. Their products are used in a wide variety of procedures, including spine, hip, and extremities. Globus Medical Inc has a market cap of 7.02B as of 2022, a Return on Equity of 7.24%. Globus Medical is committed to helping improve the quality of life for patients with musculoskeletal disorders. Their products are designed to provide solutions that enable patients to return to their active lifestyles.
– Shenzhen Mindray Bio-Medical Electronics Co Ltd ($SZSE:300760)
Shenzhen Mindray Bio-Medical Electronics Co Ltd is a medical device company that manufactures a range of medical devices and equipment. The company has a market capitalization of $366.53 billion as of 2022 and a return on equity of 23.24%. The company’s products are used in a variety of medical applications, including diagnostics, patient monitoring, and imaging.
Summary
Integer Holdings Corporation is a medical device company that provides products and services to healthcare providers. Recent investment analysis has revealed that BlackRock Inc., the world’s largest asset manager, has reduced their holdings of Integer Holdings Corporation’s stock. This news may have a negative effect on the company’s stock price, as BlackRock Inc. has been an important investor in the company. It is important for investors to keep an eye on this news and the stock price of Integer Holdings Corporation over the coming weeks.
Additionally, investors should pay attention to the company’s financials and look for any signs of financial distress or any potential opportunities for growth before investing. Finally, they should consider any potential risks that could affect their investment in Integer Holdings Corporation.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
